Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02585141Completed
Randomised, open-label trial (2 arms), sponsored by University of Southern Denmark. Primary endpoint: Abscess Recurrence Rate at 52 weeks. Started Oct 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02585141.